Charles River Laboratories International (CRL) Competitors $151.02 +0.02 (+0.02%) Closing price 06/11/2025 03:59 PM EasternExtended Trading$151.11 +0.09 (+0.06%) As of 06:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Charles River Laboratories International (NYSE:CRL) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Do insiders & institutionals have more ownership in CRL or MTD? 98.9% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor CRL or MTD? In the previous week, Charles River Laboratories International had 5 more articles in the media than Mettler-Toledo International. MarketBeat recorded 16 mentions for Charles River Laboratories International and 11 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.34 beat Charles River Laboratories International's score of 0.45 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mettler-Toledo International 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, CRL or MTD? Charles River Laboratories International has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Do analysts prefer CRL or MTD? Charles River Laboratories International currently has a consensus price target of $171.85, indicating a potential upside of 13.79%. Mettler-Toledo International has a consensus price target of $1,302.11, indicating a potential upside of 9.24%. Given Charles River Laboratories International's higher possible upside, analysts clearly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charles River Laboratories International 1 Sell rating(s) 12 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.18Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Does the MarketBeat Community favor CRL or MTD? Charles River Laboratories International received 124 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.52% of users gave Charles River Laboratories International an outperform vote while only 56.26% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformCharles River Laboratories InternationalOutperform Votes49759.52% Underperform Votes33840.48% Mettler-Toledo InternationalOutperform Votes37356.26% Underperform Votes29043.74% Is CRL or MTD more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Charles River Laboratories International0.52% 14.69% 6.79% Mettler-Toledo International 22.29%-591.54%26.78% Which has better valuation & earnings, CRL or MTD? Mettler-Toledo International has lower revenue, but higher earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCharles River Laboratories International$4.02B1.84$474.62M-$0.65-232.34Mettler-Toledo International$3.83B6.47$863.14M$40.1029.73 SummaryCharles River Laboratories International beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$7.42B$3.34B$5.57B$19.81BDividend YieldN/A2.24%5.28%3.84%P/E Ratio1,006.82121.5927.1235.67Price / Sales1.84166.87412.3046.74Price / Cash7.4834.5738.2517.52Price / Book2.232.577.064.84Net Income$474.62M$118.81M$3.23B$1.02B7 Day Performance6.85%5.17%2.86%1.94%1 Month Performance5.57%7.78%9.07%3.03%1 Year Performance-29.38%-15.57%31.45%9.73% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.7407 of 5 stars$151.02+0.0%$171.85+13.8%-28.2%$7.42B$4.02B1,006.8221,400MTDMettler-Toledo International3.7252 of 5 stars$1,196.53+1.0%$1,302.11+8.8%-17.3%$24.87B$3.83B29.5218,000Positive NewsWATWaters4.1873 of 5 stars$348.56-0.7%$390.19+11.9%+15.4%$20.74B$2.98B32.558,200Trending NewsILMNIllumina4.9023 of 5 stars$84.98+2.8%$128.84+51.6%-22.2%$13.45B$4.34B-11.0711,500Positive NewsAnalyst ForecastOptions VolumeTECHBio-Techne4.8676 of 5 stars$49.88+2.4%$72.00+44.3%-33.0%$7.82B$1.21B50.383,000BIOBio-Rad Laboratories4.7143 of 5 stars$225.84+2.9%$324.25+43.6%-18.1%$6.15B$2.54B-3.478,200Analyst ForecastAnalyst RevisionBRKRBruker4.9605 of 5 stars$39.21+2.4%$56.22+43.4%-38.4%$5.94B$3.45B51.598,520Insider TradePACBPacific Biosciences of California2.245 of 5 stars$1.20+5.3%$2.13+77.6%-36.3%$360.10M$152.36M-0.73730Gap UpHBIOHarvard Bioscience3.9174 of 5 stars$0.56+36.5%$3.00+437.3%-79.1%$24.69M$91.40M-1.69490Trending NewsShort Interest ↑Gap UpHigh Trading VolumeTMOThermo Fisher Scientific4.9763 of 5 stars$408.57+1.7%$605.30+48.2%-27.9%$154.23B$42.90B24.72130,000Positive NewsAAgilent Technologies4.6256 of 5 stars$116.77+0.8%$140.15+20.0%-9.4%$33.17B$6.51B28.8317,900Positive News Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRL Stock Free CRL Stock Alerts